Arxada Gains English High Court Sanction for Debt Restructuring Scheme
Arxada Gains English High Court Sanction for Debt Restructuring Scheme
Arxada, the Basel-headquartered ingredients and services group, reported that the High Court of Justice of England and Wales has sanctioned its English scheme of arrangement for the amend-and-extend transaction involving Herens Midco S.à r.l. and its subsidiaries. Creditors voted 100% in favour of the Scheme at the Sanction Hearing held on September 15, 2026. The Transaction, originally announced on May 12, 2026, is expected to close on September 30, 2026. Bain Capital and Cinven are named as contacts.
Completing the restructuring removes creditor uncertainty for a company with CHF 2 billion in 2025 sales across 24 production sites, supporting continuity of its chemical supply to coatings, wood protection and personal care customers.
Key facts
| Companies | Arxada, Herens Midco S.à r.l., Bain Capital, Cinven |
|---|---|
| Location | Basel, Switzerland |
| Timing | 2026-05-12, 2026-09-15, 2026-09-17, 2026-09-30 |
| Partners | Bain Capital, Cinven, creditors |
| End uses | Human Health & Nutrition, Home & Personal Care, Professional Hygiene, Paints & Coatings, Wood Protection |
Market context
Arxada is a specialty ingredients group whose products serve several end markets, including biocides and preservatives used in paints and coatings, wood protection treatments, personal care and home care formulations, and professional hygiene applications. Demand for these chemistries tends to follow construction, refurbishment, and consumer spending, while regulatory requirements on biocide approvals and product stewardship shape which active ingredients remain commercially viable. Restructuring events at specialty chemical producers generally matter to buyers because they can affect continuity of supply, service levels, and investment in plant maintenance, especially when a company runs a large multi-site manufacturing network. Lenders and investors typically watch whether creditor agreements reduce the risk of disruption to raw material sourcing or customer commitments. Competitors and downstream formulators also monitor such transactions for signs of changes in pricing behavior or product portfolio focus, although the impact on the wider market usually depends on how operations and commercial terms develop after completion.
Source: official release on arxada.com. Summary and context written by Market Krystal.
About Arxada
Microbial control & specialty · Switzerland · No. 376 in the Market Krystal chemical company ranking · chemical sales about $1B.
Need the market behind this story?
Market Krystal can send a report sample or a scope for this chemical, company or market. An analyst replies within 24 hours.